Ipamorelin/Tesamorelin 10mg
Dual peptide blend: Ipamorelin (5mg) + Tesamorelin (5mg) — GHS-R agonist paired with GHRH analog Two distinct GH-axis receptor targets in a single co-lyophilized vial For in vitro dual-mechanism GH-axis research only
For laboratory research use only. Not for human or veterinary consumption. SKU IPTESA55.
Product details.
Component breakdown
Ipamorelin (5mg)
Selective GHS-R agonist pentapeptide. CAS 170851-70-4. MW 711.85 g/mol. Characterized by Raun et al. as the first GH secretagogue with selectivity comparable to GHRH itself.
Tesamorelin (5mg)
Full-length GHRH analog (all 44 amino acids) with N-terminal lipophilic stabilization. CAS 218949-48-5. MW 5135.83 g/mol. A structurally different approach to GHRH receptor agonism than the truncated, tetra-substituted CJC-1295.
Why this pairing
GHRH receptor activation and ghrelin receptor signaling converge on pituitary somatotrophs through complementary cascades. Preclinical literature has characterized how these two inputs interact — the GHRH pathway through cAMP/PKA, the GHS-R pathway through PLC/IP3/calcium. Studying both under identical experimental conditions in a single reconstitution eliminates variability from separate preparations.
Specifications
| Content | 5mg Ipamorelin + 5mg Tesamorelin per vial |
| Format | Co-lyophilized powder |
| Testing | Third-party tested, both components verified |
Storage
- Lyophilized: -20°C
- Reconstituted: 2-8°C, use within 30 days
For laboratory research use only. Not for human or veterinary use.
Technical reference adapted from the original Heritage Labs USA product listing. This description is not a certificate of analysis or evidence of testing for inventory supplied by this store.
